IOVA
IOVA
NASDAQ · Biotechnology

Iovance Biotherapeutics Inc

$6.34
+0.13 (+2.09%)
As of Aug 8, 10:12 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target +763.9% upside
Low Target $41.45
Average Target $54.77
High Target $77.23
Current Price $6.34
Current
$6.34
Target
$54.77
$41.45 $54.77 avg $77.23
Scenario Analysis
Bear Case
$41.45
553.8%
Low target
Base Case
$54.77
+763.9%
Avg target
Bull Case
$77.23
+1,118.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.39
-0.8% from high
52-Week Low
$1.76
+260.2% from low
50-Day SMA
$4.30
+47.4% vs SMA
RSI (14)
55.3
Neutral
Target vs 52W High
$54.77
+757.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%